BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22919576)

  • 1. Characterization of recombinant B. abortus strain RB51SOD toward understanding the uncorrelated innate and adaptive immune responses induced by RB51SOD compared to its parent vaccine strain RB51.
    Zhu J; Larson CB; Ramaker MA; Quandt K; Wendte JM; Ku KP; Chen F; Jourdian GW; Vemulapalli R; Schurig GG; He Y
    Front Cell Infect Microbiol; 2011; 1():10. PubMed ID: 22919576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live Brucella abortus rough vaccine strain RB51 stimulates enhanced innate immune response in vitro compared to rough vaccine strain RB51SOD and virulent smooth strain 2308 in murine bone marrow-derived dendritic cells.
    Surendran N; Hiltbold EM; Heid B; Sriranganathan N; Boyle SM; Zimmerman KL; Makris MR; Witonsky SG
    Vet Microbiol; 2011 Jan; 147(1-2):75-82. PubMed ID: 20594772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51.
    Vemulapalli R; He Y; Cravero S; Sriranganathan N; Boyle SM; Schurig GG
    Infect Immun; 2000 Jun; 68(6):3286-9. PubMed ID: 10816475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice.
    Retamal-Díaz A; Riquelme-Neira R; Sáez D; Rivera A; Fernández P; Cabrera A; Guzmán CA; Oñate A
    Clin Vaccine Immunol; 2014 Nov; 21(11):1474-80. PubMed ID: 25165025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of Brucella abortus rough vaccine strains to elicit DC and innate immunity in lung using a murine respiratory model.
    Surendran N; Zimmerman K; Seleem MN; Sriranganathan N; Boyle SM; Hiltbold EM; Lawler H; Heid B; Witonsky SG
    Vaccine; 2010 Oct; 28(43):7009-15. PubMed ID: 20727395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2.
    González-Smith A; Vemulapalli R; Andrews E; Oñate A
    Immunobiology; 2006; 211(1-2):65-74. PubMed ID: 16446171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses.
    Vemulapalli R; He Y; Boyle SM; Sriranganathan N; Schurig GG
    Infect Immun; 2000 Jun; 68(6):3290-6. PubMed ID: 10816476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucella abortus RB51: enhancing vaccine efficacy and developing multivalent vaccines.
    Vemulapalli R; He Y; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2002 Dec; 90(1-4):521-32. PubMed ID: 12414168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type.
    He Y; Vemulapalli R; Schurig GG
    Infect Immun; 2002 May; 70(5):2535-43. PubMed ID: 11953393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA; Donoso G; Moraga-Cid G; Folch H; Céspedes S; Andrews E
    Infect Immun; 2005 Jun; 73(6):3294-300. PubMed ID: 15908354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus.
    Oñate AA; Vemulapalli R; Andrews E; Schurig GG; Boyle S; Folch H
    Infect Immun; 1999 Feb; 67(2):986-8. PubMed ID: 9916121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.
    Surendran N; Sriranganathan N; Lawler H; Boyle SM; Hiltbold EM; Heid B; Zimmerman K; Witonsky SG
    Vaccine; 2011 Mar; 29(15):2749-55. PubMed ID: 21316499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes.
    Olsen SC; Boyle SM; Schurig GG; Sriranganathan NN
    Clin Vaccine Immunol; 2009 Apr; 16(4):535-40. PubMed ID: 19176693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Brucella abortus phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice.
    Trant CG; Lacerda TL; Carvalho NB; Azevedo V; Rosinha GM; Salcedo SP; Gorvel JP; Oliveira SC
    Infect Immun; 2010 May; 78(5):2283-91. PubMed ID: 20194591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.
    Dabral N; Burcham GN; Jain-Gupta N; Sriranganathan N; Vemulapalli R
    PLoS One; 2019; 14(3):e0213587. PubMed ID: 30856219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA; Céspedes S; Cabrera A; Rivers R; González A; Muñoz C; Folch H; Andrews E
    Infect Immun; 2003 Sep; 71(9):4857-61. PubMed ID: 12933826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
    Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.